🇺🇸 FDA
Patent

US 9994910

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

granted A61PA61P35/00

Quick answer

US patent 9994910 (Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571) held by The Regents of the University of California expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P35/00